Skip to main content

Table 4 Unit costs

From: Cost-effectiveness analysis of pemetrexed versus docetaxel in the second-line treatment of non-small cell lung cancer in Spain: results for the non-squamous histology population

Resource

Price (€)

Source

Dexamethasone 1 mg tablets × 30 (Fortecortin®)

2.97

[14]

Folic Acid 400 mcg tablets × 28 (Zolico®)

3.39

 

Vitamin B12 1 mg vial × 8 (Cromatonbic®)

3.12

 

Pemetrexed (100 mg vial)

297.35

 

Pemetrexed (500 mg vial)

1295.75

 

Docetaxel (20 mg vial)

190.09

 

Docetaxel (80 mg vial)

604.43

 

Complete Blood Count includes white cell differential

16.05

[16]

Biochemical Analysis includes renal function and liver function tests

24.78

 

Chemotherapy administration < 2 hours clinic time

135.21

[16]

Neutropenia

2086.13

Expert panel, [18]

Nausea and Vomiting

516.20

 

Fatigue

575.30

 

Diarrhoea

691.04

 

Alopecia (Hair loss)

0.00

 

Rash

64.74

 

Febrile Neutropenia

3310.85

 

BSC costs

 

Expert panel

   Cost of weighted home visit per 21 day cycle

125.83

 

   Cost of weighted outpatient visit per 21 day cycle

41.64

 

Total BSC cost per 21 day cycle

167.47

 

Terminal/Palliative care (weighted one-off cost)

23660.91

Expert panel

  1. BSC: best supportive care
  2. Unit costs and sources for all resource used in the model.